Li JY - Search Results

Year	Number of Results
1964	1
1965	1
1974	2
1976	1
1977	3
1979	2
1980	2
1981	1
1982	5
1983	8
1984	4
1985	15
1986	4
1987	8
1988	9
1989	12
1990	11
1991	16
1992	24
1993	17
1994	28
1995	13
1996	16
1997	16
1998	15
1999	30
2000	20
2001	28
2002	28
2003	79
2004	61
2005	85
2006	89
2007	123
2008	143
2009	154
2010	168
2011	174
2012	234
2013	209
2014	162
2015	204
2016	204
2017	192
2018	237
2019	255
2020	281
2021	307
2022	330
2023	314
2024	369
2025	280

1

TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models.

Li JY, Zhao Y, Gong S, Wang MM, Liu X, He QM, Li YQ, Huang SY, Qiao H, Tan XR, Ye ML, Zhu XH, He SW, Li Q, Liang YL, Chen KL, Huang SW, Li QJ, Ma J, Liu N. Li JY, et al. Nat Commun. 2023 Feb 16;14(1):865. doi: 10.1038/s41467-023-36523-y. Nat Commun. 2023. PMID: 36797289 Free PMC article.

2

Single-cell transcriptome profiling of sepsis identifies HLA-DR^lowS100A^high monocytes with immunosuppressive function.

Yao RQ, Zhao PY, Li ZX, Liu YY, Zheng LY, Duan Y, Wang L, Yang RL, Kang HJ, Hao JW, Li JY, Dong N, Wu Y, Du XH, Zhu F, Ren C, Wu GS, Xia ZF, Yao YM. Yao RQ, et al. Among authors: li jy. Mil Med Res. 2023 Jun 19;10(1):27. doi: 10.1186/s40779-023-00462-y. Mil Med Res. 2023. PMID: 37337301 Free PMC article.

3

Reversible male contraception by targeted inhibition of serine/threonine kinase 33.

Ku AF, Sharma KL, Ta HM, Sutton CM, Bohren KM, Wang Y, Chamakuri S, Chen R, Hakenjos JM, Jimmidi R, Kent K, Li F, Li JY, Ma L, Madasu C, Palaniappan M, Palmer SS, Qin X, Robers MB, Sankaran B, Tan Z, Vasquez YM, Wang J, Wilkinson J, Yu Z, Ye Q, Young DW, Teng M, Kim C, Matzuk MM. Ku AF, et al. Among authors: li jy. Science. 2024 May 24;384(6698):885-890. doi: 10.1126/science.adl2688. Epub 2024 May 23. Science. 2024. PMID: 38781365 Free PMC article.

4

Metaplastic regeneration in the mouse stomach requires a reactive oxygen species pathway.

Miao ZF, Sun JX, Huang XZ, Bai S, Pang MJ, Li JY, Chen HY, Tong QY, Ye SY, Wang XY, Hu XH, Li JY, Zou JW, Xu W, Yang JH, Lu X, Mills JC, Wang ZN. Miao ZF, et al. Among authors: li jy. Dev Cell. 2024 May 6;59(9):1175-1191.e7. doi: 10.1016/j.devcel.2024.03.002. Epub 2024 Mar 22. Dev Cell. 2024. PMID: 38521055 Free article.

5

Videos in Short-Video Sharing Platforms as Sources of Information on Colorectal Polyps: Cross-Sectional Content Analysis Study.

Guan JL, Xia SH, Zhao K, Feng LN, Han YY, Li JY, Liao JZ, Li PY. Guan JL, et al. Among authors: li jy. J Med Internet Res. 2024 Oct 29;26:e51655. doi: 10.2196/51655. J Med Internet Res. 2024. PMID: 39470708 Free PMC article.

6

XELOX (capecitabine plus oxaliplatin) plus bevacizumab (anti-VEGF-A antibody) with or without adoptive cell immunotherapy in the treatment of patients with previously untreated metastatic colorectal cancer: a multicenter, open-label, randomized, controlled, phase 3 trial.

Pan QZ, Zhao JJ, Liu L, Zhang DS, Wang LP, Hu WW, Weng DS, Xu X, Li YZ, Tang Y, Zhang WH, Li JY, Zheng X, Wang QJ, Li YQ, Xiang T, Zhou L, Yang SN, Wu C, Huang RX, He J, Du WJ, Chen LJ, Wu YN, Xu B, Shen Q, Zhang Y, Jiang JT, Ren XB, Xia JC. Pan QZ, et al. Among authors: li jy. Signal Transduct Target Ther. 2024 Apr 3;9(1):79. doi: 10.1038/s41392-024-01788-2. Signal Transduct Target Ther. 2024. PMID: 38565886 Free PMC article. Clinical Trial.

7

PJA1-mediated suppression of pyroptosis as a driver of docetaxel resistance in nasopharyngeal carcinoma.

Huang SY, Gong S, Zhao Y, Ye ML, Li JY, He QM, Qiao H, Tan XR, Wang JY, Liang YL, Huang SW, He SW, Li YQ, Xu S, Li YQ, Liu N. Huang SY, et al. Among authors: li jy. Nat Commun. 2024 Jun 21;15(1):5300. doi: 10.1038/s41467-024-49675-2. Nat Commun. 2024. PMID: 38906860 Free PMC article.

8

Tissue-resident microbiota signature in nasopharyngeal carcinoma.

Tan XR, Qiao H, Li YQ, Jiang W, Huang SY, Gong S, Li WF, Tang LL, Zhou GQ, Liang YL, Li H, He QM, Bai JW, Ye ML, Wang JY, Huang SW, Li JY, Gan CQ, Li YQ, Zhao Y, Sun Y, Ma J, Liu N. Tan XR, et al. Among authors: li jy. Microbiome. 2025 May 17;13(1):125. doi: 10.1186/s40168-025-02114-w. Microbiome. 2025. PMID: 40382629 Free PMC article.

9

LncRNA DYNLRB2-AS1 promotes gemcitabine resistance of nasopharyngeal carcinoma by inhibiting the ubiquitination degradation of DHX9 protein.

Chen KL, Huang SW, Yao JJ, He SW, Gong S, Tan XR, Liang YL, Li JY, Huang SY, Li YQ, Zhao Y, Qiao H, Xu S, Zang S, Ma J, Liu N. Chen KL, et al. Among authors: li jy. Drug Resist Updat. 2024 Sep;76:101111. doi: 10.1016/j.drup.2024.101111. Epub 2024 Jun 14. Drug Resist Updat. 2024. PMID: 38908233

10

Structures of the ADGRG2-G_s complex in apo and ligand-bound forms.

Lin H, Xiao P, Bu RQ, Guo S, Yang Z, Yuan D, Zhu ZL, Zhang CX, He QT, Zhang C, Ping YQ, Zhao RJ, Ma CS, Liu CH, Zhang XN, Jiang D, Huang S, Xi YT, Zhang DL, Xue CY, Yang BS, Li JY, Lin HC, Zeng XH, Zhao H, Xu WM, Yi F, Liu Z, Sun JP, Yu X. Lin H, et al. Among authors: li jy. Nat Chem Biol. 2022 Nov;18(11):1196-1203. doi: 10.1038/s41589-022-01084-6. Epub 2022 Aug 18. Nat Chem Biol. 2022. PMID: 35982227

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,552 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,552 results

Results by year